Chapter 3: Pharmacokinetics Flashcards
Pharmacokinetics
ADME
-Reaching site of action
a. Most drugs have to travel through several membranes (uncharge more likely to cross membranes)
-Absorption
a. Permeation
-Distribution
Aqueous Diffusion
-Larger aqueous compartments (cytosol, interstitial space)
-Aqueous channel/Aquaporins
a. Allow H2O to pass through, so molecule going with H2O
Flux: amount of flow through aqueous channel (directly proportional to concentration gradient)
- Diffusion by concentration gradient
a. Greater concentration to lower
-Molecules can be quiet large
Lipid Diffusion
-No transporter or pore to travel through
–Lipid soluble drugs
pH vs. pKa
- Uncharged more likely to cross through barrier
Special Carriers
Molecules bind to drug & move across barrier
Types:
A. Active Transport
-Require ATP to move against concentration gradient
B. Facilitated Diffusion
-Moves through with gradient without the use of ATP
NET –> Norepi reuptake
SERT –> Serotonin reuptake
MDR1 –> xenobiotics
VMAT –> dopamine and norepinephrine
Endocytosis vs. Exocytosis
Endocytosis:
- Membrane engulfment
a. Receptor mediated endocytosis (ex. clathrin coated pits)
b. Outside cell to inside cell
Exocytosis:
- merging of vesicle with membrane
-inside cell to outside cell
Volume of Distribution (Vd)
- Amount of drug in body to concentration in blood per 70 kg
a. Conc. L/ 70 kg - Whole blood: 0.08 L/kg
- Plasma: 0.04 L/kg
- High Vd means it preferentially leaves the blood stream/distributed outside of the blood stream
Multiply by % to get Vd
Clearance (CL)
Predicts rate of elimination in relation to Concentration (C)
CL= ROE/C
-Clearance is additive if eliminated in different parts of the body
Rate of Elimination (ROE)
Rate at which drug leaves body
Types:
- First Order
- Zero Order (Capacity Limited)
- Flow Dependent
Half-life (T 1/2)
Amount of time it takes to reduce concentration by half the amount
After 4 half-lives, effectively eliminate drug
-Accumulation: will build up until dosing stops, especially if dosing interval is less than 4 half-lives
Bioavailability (F)
Fraction of unchanged drug reaching systemic circulation
-Only IV administration will have 100%
Capacity Limited Clearance/ Zero order Elimination
Rate of elimination is constant
- Clearance varies
- Amount of drug being cleared is constant (ROE) because all transporters are being used
- If given enough drug (toxic level, maybe) first order elimination drugs can turn into zero order
First Order Clearance
Drug eliminated at a constant clearance, so amount of drug being eliminated is less and less
- ROE decreases
Flow Dependent Elimination
Depends on blood flow through an organ (I.e liver)
-First pass effect
“High Extraction Drugs”
- Every time they go through that organ, large proportion will be removed
CL(org)= Q x E
Q: blood flow through organ
E: Extraction Ratio
High Q and High E results in High CL (L/hr)
Routes of Drug Administration
- IV –> 100 % Bioavailable
- IM 75 to < or = 100% Bioavailable
- SQ 75 to < or = 100% Bioavailable
- Oral 5 to < 100% bioavailable
- Rectal 30 to <100%
- Inhalation 5 to <100%
- Transdermal 80 to < or = 100%
Loading Dose/ Bolus Dose
Used to achieve TC more rapidly than 4 half-lives
Considers Vd
LD= Vd x TC
Maintenance Dose
Maintain steady state of drug by giving just enough to replace amount being eliminated
-Clearance most important factor
-Dosing Rate= CL x TC
- F <100%; DR= DR calc/ F (bioavailable)
Intermittent
-Dose Rate x Dosing interval
Ideal Body Weight Calculation
Male: 52 + (1.9 kg x inches over 5 ft)
Female: 49 + (1.7 kg x inches over 5 ft)
Therapeutic Drug Monitoring
-Peak: Usually taken after drug reaches blood stream
a. make sure enough target concentration is bioavailable to have appropriate effect
-Trough: Drawn prior to next dose
b. make sure drug is leaving system appropriately so not to build up toxic levels
ex) gentamicin, vancomycin, phenytoin
Kidney Function test
Creatinine clearance
Target Concentration (TC)
Concentration needed to produce desired effect
Takes 4 half-lives to reach target concentration
Determined for every drug, every individual, determined experimentally
TC is therapeutically determine
ex) Digoxin 2 ng/mL for Afib but 1 ng/mL for Heart Failure